Episode 11 – Interview with Dr. Donald Arnold, lead for the CONCOR-1 trial

Welcome back Rounds Table Listeners!

This week we interview Dr. Donald Arnold, a McMaster University professor and hematologist who is leading the CONCOR-1 trial.

The CONvalescent Plasma for COVID-19 Research Trial (CONCOR-1), is a North American clinical trial designed to evaluate the efficacy and safety of COVID-19 convalescent plasma as a therapy for patients with COVID-19 respiratory illness.

It involves collecting plasma containing neutralizing antibodies from individuals who have recovered from the infection and transfusing it to patients with acute COVID-19 infection.

You can find out more information about the CONCOR-1 trial here:

Questions? Comments? Feedback? We’d love to hear from you.

Leave a Comment

Your email address will not be published. Required fields are marked *

  • Susan Saranchuk says:

    Very Interesting and exciting. Unfortunately, the most I can do for Dr. Arnold is cross my fingers, which I have done. Working while I was listening so I might have missed it, but how long does this study last?

  • Nancy says:

    Great session. So good to learn about Dr. Arnold’s fascinating study.

Republish this article

Republish this article on your website under the creative commons licence.

Learn more